College of Pharmacy, Freie Universität Berlin, Kelchstrasse 31, 12169 Berlin, Germany.
Int J Pharm. 2010 Dec 15;402(1-2):72-7. doi: 10.1016/j.ijpharm.2010.09.021. Epub 2010 Sep 29.
The goal of this study was to obtain flexible extended drug release profiles (e.g., sigmoidal, pulsatile, increasing/decreasing release rates with time) with hydroxypropyl methylcellulose (HPMC) compression-coated tablets. Drugs of varying solubility (carbamazepine, acetaminophen, propranolol HCl and chlorpheniramine maleate) were incorporated into the tablet core in order to evaluate the flexibility/limitations of the compression-coated system. The HPMC-compression-coating resulted in release profiles with a distinct lag time followed by different release phases primarily determined by the drug solubility. Carbamazepine, a water-insoluble drug, was released in a pulsatile fashion after a lag time only after erosion of the HPMC compression-coat, while the more soluble drugs were released in a sigmoidal fashion by diffusion through the gel prior to erosion. With carbamazepine, increasing the molecular weight of HPMC significantly increased the lag time because of the erosion-based release mechanism, while, in contrast, molecular weight did not affect the release of the more soluble drugs. The lag-time and the release rate could also be well controlled by varying the HPMC amount in and the thickness of the compression-coating. A pulsatile release could also be achieved for water-soluble drugs by introducing an enteric polymer coating between the drug core and the HPMC compression-coating. This novel concept of introducing an enteric subcoating eliminated drug diffusion through the gelled HPMC layer prior to its erosion. Incorporating drug in the compression-coating in addition to the tablet core in varying ratios resulted in release profiles with increasing, decreasing or constant release rates. In conclusion, a versatile single-unit delivery system for a wide range of drugs with great flexibility in release profiles was presented.
本研究的目的是获得具有柔性的延长药物释放曲线(例如,S 型、脉冲型、随时间增加/减少释放速率)的羟丙甲纤维素(HPMC)压制包衣片。将不同溶解度的药物(卡马西平、对乙酰氨基酚、盐酸普萘洛尔和马来酸氯苯那敏)掺入片剂核心,以评估压缩包衣系统的灵活性/局限性。HPMC 压缩包衣导致释放曲线具有明显的滞后时间,随后是不同的释放阶段,主要由药物溶解度决定。卡马西平是一种不溶于水的药物,在 HPMC 压缩包衣侵蚀后仅在滞后时间后以脉冲方式释放,而更易溶的药物则通过凝胶扩散在侵蚀前以 S 型方式释放。对于卡马西平,由于基于侵蚀的释放机制,HPMC 的分子量显著增加会显著增加滞后时间,而相反,分子量不会影响更易溶的药物的释放。通过改变压缩包衣中的 HPMC 量和厚度,也可以很好地控制滞后时间和释放速率。通过在药物核心和 HPMC 压缩包衣之间引入肠溶性聚合物涂层,也可以实现水溶性药物的脉冲释放。该新颖概念通过在其侵蚀之前消除药物通过凝胶化 HPMC 层的扩散,引入肠溶性亚涂层。除了片剂核心外,以不同比例将药物掺入压缩包衣中,可得到具有增加、减少或恒定释放速率的释放曲线。总之,提出了一种具有广泛适用性的单单位药物输送系统,对于药物释放曲线具有很大的灵活性。